Associations of Cytokine Polymorphisms with Immunosenescence

  • Elissaveta Naumova
  • Milena Ivanova


Deterioration of the immune system with aging is associated with an increased susceptibility to infectious diseases, cancer and autoimmune disorders. It has been demonstrated that immunosenescence is associated with chronic, lowgrade inflammatory activity. The aging process is very complex and longevity is a multifactorial trait, which is determined by genetic and environmental factors, and the interaction of “disease” processes with “intrinsic” ageing processes. It is hypothesized that the level of immune response as well as possibly longevity could be associated with genes regulating immune functions. It is further hypothesized that the diversity of these genes might influence successful aging and longevity by modulating an individual’s response to life-threatening disorders. Several studies have focused on the role of genes encoding molecules with immune functions. In this chapter we will review the data on the role of cytokine gene polymorphisms in human longevity.

Cytokines Cytokine gene polymprphisms Immunosenescence Longevity 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abraham LJ, French MA, Dawkins RL (1993) Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha. Clin Exp Immunol 92:14–18PubMedGoogle Scholar
  2. Bendtzen K, Morling N, Fomsgaard A et al (1988) Association between HLA-DR2 and production of tumour necrosis factor alpha and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand J Immunol 28:599–606PubMedCrossRefGoogle Scholar
  3. Bhojak TJ, DeKosky ST, Ganguli M et al (2000) Genetic polymorphisms in the cathespin D and interleukin-6 genes and the risk of Alzheimer’s disease. Neurosci Lett 288:21–24PubMedCrossRefGoogle Scholar
  4. Bidwell J, Keen L, Gallagher G et al (1999) Human cytokine gene nucleotide sequence alignments: supplement 1. Eur J Immunogenet 26:135–223PubMedCrossRefGoogle Scholar
  5. Bidwell J, Keen L, Gallagher G et al (2001) Cytokine gene polymorphism in human disease: online databases, supplement 1. Genes Immun 2:61–70PubMedCrossRefGoogle Scholar
  6. Bonafe M, Olivieri F, Cavallone L et al (2001) A gender-dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur J Immunol 31:2357–2361PubMedCrossRefGoogle Scholar
  7. Browner WS, Kahn AJ, Ziv E, Reiner AP, Oshima, J, Cawthon RM, Hsueh WC, Cummings SR (2004) The genetics of human longevity. Am J Med 117:851–860PubMedCrossRefGoogle Scholar
  8. Bruunsgaard H, Benfield TL, Andersen-Ranberg K et al (2004) The tumor necrosis factor alpha-308G>A polymorphism is associated with dementia in the oldest old. J Am Geriatr Soc 52:1361–1366PubMedCrossRefGoogle Scholar
  9. Bruunsgaard H, Pedersen M, Pedersen BK (2001) Aging and proinflammatory cytokines. Curr Opin Hematol 8:131–136PubMedCrossRefGoogle Scholar
  10. Bruunsgaard H, Skinhoj P, Qvist J et al. 1999. Elderly humans show prolonged in vivo inflammatory activity during pneumococcal infections. J Infect Dis. 180, 551–554PubMedCrossRefGoogle Scholar
  11. Candore G, Lio D, Colonna Romano G, Caruso C (2002) Pathogenesis of autoimmune diseases associated with 8.1ancestral haplotype: Effect of multiple gene interactions. Autoimmun Rev 1:29–35PubMedCrossRefGoogle Scholar
  12. Capurso C, Solfrizzi V, D’Introno A, Colacicco AM, Capurso SA, Semeraro C, Capurso A, Panza F (2004) Interleukin 6-174 G/C promoter gene polymorphism in centenarians: No evidence of association with human longevity or interaction with apolipoprotein E alleles. Exp Gerontol 39:1109–1114PubMedCrossRefGoogle Scholar
  13. Carrieri G, Marzi E, Olivieri F, Marchegiani F, Cavallone L, Cardelli M, Giovagnetti S, Stecconi R, Molendini C, Trapassi C, De Benedictis G, Kletsas D, Franceschi C (2004) The G/C915 polymorphism of transforming growth factor beta1 is associated with human longevity: A study in Italian centenarians. Aging Cell 3:443–448PubMedCrossRefGoogle Scholar
  14. Caruso C, Candore G, Colonna Romano G et al (2000) HLA, aging, and longevity: a critical reappraisal. Hum Immunol 61:942–949PubMedCrossRefGoogle Scholar
  15. Cavallone L, Bonafe M, Olivieri F et al (2003) The role of IL-1 gene cluster in longevity: a study in Italian population. Mech Ageing Dev 124:533–538PubMedCrossRefGoogle Scholar
  16. centenarians. Aging Clin Exp Res 16:244–248Google Scholar
  17. Chamorro A (2004) Role of inflammation in stroke and atherothrombosis. Cerebrovasc Dis 7 (Suppl 3):1–5CrossRefGoogle Scholar
  18. Christiansen L, Bathum L, Andersen-Ranberg K, Jeune B, Christensen K (2004) Modest implication of interleukin-6 promoter polymorphisms in longevity. Mech Ageing Dev 125:391–395PubMedCrossRefGoogle Scholar
  19. Cohen HJ, Pieper CF, Harris T et al (1997) The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol A Biol Sci Med Sci 52:201–208Google Scholar
  20. Crawley E, Kay R, Sillibourne J et al (1999) Polymorphic haplotypes of the interleukin-10 5’flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 42:1101–1108PubMedCrossRefGoogle Scholar
  21. D’Alfonso S, Rampi M, Rolando V et al (2000) New polymorphisms in the IL-10 promoter region. Genes Immun 1:231–233PubMedCrossRefGoogle Scholar
  22. Dalziel B, Gosby AK, Richman R et al (2002) Association of the TNF-alpha -308 G/A promoter polymorphism with insulin resistance in obesity. Obes Res 10:401–407PubMedCrossRefGoogle Scholar
  23. Dandona P, Aljada A, Bandyopadhyay A (2004) Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25:4–7PubMedCrossRefGoogle Scholar
  24. Demoulin JB and Renauld JC (1998). Signalling by cytokines interacting with the interleukin-2 receptor gamma chain. Cytokines Cell Mol Ther:243–256Google Scholar
  25. down-regulates expression of chemokine stromal cell-derived factor-1: Functional consequences in cell migration and adhesion. Blood 102:1978–1984Google Scholar
  26. Ershler WB, Keller ET (2000) Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 51:245–270PubMedCrossRefGoogle Scholar
  27. Eskdale J, Gallagher G, Verweij C et al (1998) Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci U S A 95:9465–9470PubMedCrossRefGoogle Scholar
  28. Ferrucci L, Harris TB, Guralnik JM et al (1999) Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc 47:639–646PubMedGoogle Scholar
  29. Fishman D, Faulds G Jeffery R et al (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemiconset juvenile chronic arthritis. J Clin Invest 102:1369–1376PubMedCrossRefGoogle Scholar
  30. Forsey RJ, Thompson J, Ernerudh J et al (2003) Plasma cytokine profiles in elderly humans. Mech Ageing Dev 124:487–493PubMedCrossRefGoogle Scholar
  31. Franceschi C, Bonafe M, Valensin S et al (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908:244–254PubMedCrossRefGoogle Scholar
  32. Franceschi C, Olivieri F, Marchegiani F, Cardelli M, Cavallone L, Capri M, Salvioli S, Valensin S, De Benedictis G, Di Iorio A, Caruso C, Paolisso G, Monti D (2005) Genes involved in immune response/inflammation, IGF1/insulin pathway and response to oxidative stress play a major role in the genetics of human longevity: The lesson of centenarians. Mech Ageing Dev 126:351–361PubMedCrossRefGoogle Scholar
  33. Georges JL, Loukaci V, Poirier O et al (2001) Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. Etude Cas-Temoin de l’Infarctus du Myocarde. J Mol Med 79:300–305PubMedCrossRefGoogle Scholar
  34. Girndt M, Kaul H, Sester U et al (2002) Anti- inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events. Kidney Int 62:949–955PubMedCrossRefGoogle Scholar
  35. Hajeer AH, Hutchinson IV (2001) Influence of TNF alpha gene polymorphisms on TNF alpha production and disease. Hum Immunol 62:1191–1199PubMedCrossRefGoogle Scholar
  36. Hajeer AH, Lazarus M, Turner D et al (1998) IL-10 gene promoter polymorphisms in rheumatoid arthritis. Scand J Rheumatol 27:142–145PubMedCrossRefGoogle Scholar
  37. Harris TB, Ferrucci L, Tracy RP et al (1999) Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106:506–512PubMedCrossRefGoogle Scholar
  38. Heijmans BT, Westendorp RG, Droog S et al (2002) Association of the tumour necrosis factor alpha -308G/A polymorphism with the risk of diabetes in an elderly population-based cohort. Genes Immun 3:225–228PubMedCrossRefGoogle Scholar
  39. Heinrich PC, Behrmann I, Haan S et al (2003) Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374:1–20PubMedCrossRefGoogle Scholar
  40. Helfand SL, Rogina B (2003). Molecular genetics of aging in the fly: is this the end of the beginning? Bioessays 25:134–141PubMedCrossRefGoogle Scholar
  41. Hoffmann SC, Stanley EM, Darrin Cox E, Craighead N, DiMercurio BS, Koziol DE, Harlan DM, Kirk AD and Blair PJ (2001) Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes. Transplantation 8:1444–1450CrossRefGoogle Scholar
  42. Howell WM, Turner SJ, Bateman A et al (2001) IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma. Genes Immun 2:25–31PubMedCrossRefGoogle Scholar
  43. Humphries SE, Luong LA, Ogg M et al (2001) The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men.Eur Heart J 22:2243–52PubMedCrossRefGoogle Scholar
  44. Hurme M, Lehtimaki T, Jylha M, Karhunen PJ, Hervonen A (2005) Interleukin-6-174G/C polymorphism and longevity: A follow-up study. Mech Ageing Dev 126:417–418PubMedCrossRefGoogle Scholar
  45. Hutchinson IV, Pravica V, Perrey C et al (1999) Cytokine gene polymorphisms and relevance to forms of rejection. Transplant Proc 31:734–736PubMedCrossRefGoogle Scholar
  46. Jacob CO, Fronek Z, Lewis G et al 1990. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci U S A 87:1233–1237PubMedCrossRefGoogle Scholar
  47. Kirkwood TB (2002) Evolution of ageing. Mech. Ageing Dev 123:737–745PubMedCrossRefGoogle Scholar
  48. Kruglyak L (1999) Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet 22:139–144PubMedCrossRefGoogle Scholar
  49. Kube D, Rieth H, Eskdale J et al (2001) Structural characterisation of the distal 5’ flanking region of the human interleukin-10 gene. Genes Immun 2:181–190PubMedCrossRefGoogle Scholar
  50. Lindemans CA, Coffer PJ, Schellens IM, de Graaff PM, Kimpen JL, Koenderman L (2006) Respiratory syncytial virus inhibits granulocyte apoptosis through a phosphatidylinositol 3-kinase and NF-kappaB-dependent mechanism. J Immunol 176:5529–5537PubMedGoogle Scholar
  51. Lio D, Candore G, Colombo A et al (2001) A genetically determined high setting of TNF-alpha influences immunologic parameters of HLA-B8,DR3 positive subjects: implications for autoimmunity. Hum Immunol 62:705–713PubMedCrossRefGoogle Scholar
  52. Lio D, Scola L, Crivello A et al (2002) Gender-specific association between -1082 IL-10 promoter polymorphism and longevity. Genes Immun 3:30–33PubMedCrossRefGoogle Scholar
  53. Lio D, Scola L, Crivello A et al (2002) Allele frequencies of +874T–>A single nucleotide polymorphism at the first intron of interferon-gamma gene in a group of Italian centenarians. Exp Gerontol 37:315–319PubMedCrossRefGoogle Scholar
  54. Lio D, Scola L, Crivello A et al (2002) Gender-specific association between -1082 IL-10 promoter polymorphism and longevity. Genes Immun 3:30–33PubMedCrossRefGoogle Scholar
  55. Lio D, Scola L, Crivello A et al (2003) Inflammation, genetics, and longevity: further studies on the protective effects in men of IL-10 -1082 promoter SNP and its interaction with TNF-alpha -308 promoter SNP. J Med Genet 40:296–299PubMedCrossRefGoogle Scholar
  56. Makhatadze NJ (1998) Tumor necrosis factor locus: genetic organisation and biological implications. Hum Immunol 59:571–579PubMedCrossRefGoogle Scholar
  57. Mitchell BD, Hsueh WC, King TM, Pollin TI, Sorkin J, Agarwala R, Schaffer AA, Shuldiner AR (2001) Heritability of life span in the Old Order Amish. Am J Med Genet 102:346–352PubMedCrossRefGoogle Scholar
  58. Moore KW, de Waal Malefyt R, Coffman RL et al (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683–765PubMedCrossRefGoogle Scholar
  59. My-Chan Dang P, Elbim C, Marie JC, Chiandotto M, Gougerot-Pocidalo MA, El-Benna J (2006) Anti-inflammatory effect of interleukin-10 on human neutrophil respiratory burst involves inhibition of GM-CSF-induced p47PHOX phosphorylation through a decrease in ERK1/2 activity. FASEB 23Google Scholar
  60. Nauck M, Winkelmann BR, Hoffmann M et al (2002) The interleukin-6 G(-174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarction. J Mol Med 80:507–513PubMedCrossRefGoogle Scholar
  61. Naumova E, Mihaylova A, Ivanova M et al (2004) Immunological markers contributing to sucsessful aging in Bulgarians. Exp Gerontol 39:637–644PubMedCrossRefGoogle Scholar
  62. O’Keefe GE, Hybki DL, Munford RS (2002) The G A single nucleotide polymorphism at the -308 position in the tumor necrosis factor-alpha promoter increases the risk for severe sepsis after trauma. J Trauma 52:817–825PubMedCrossRefGoogle Scholar
  63. Pawelec G, Barnett Y, Forsey R, Frasca D, Globerson A, McLeod J, Caruso C, Franceschi C, Fulop T, Gupta S, Mariani E, Mocchegiani E, Solana R (2002) T cells and aging Front. Bioscience 7:1056–1183Google Scholar
  64. Pes G, Lio D, Carru C, Deiana L, Baggio G, Franceschi C, Ferrucci L, Oliveri F, Scola L, Crivello A, Candore G, Colonna-Romano G, Caruso C (2004) Association between longevity and cytokine gene polymorphisms. A study in SardinianGoogle Scholar
  65. Pravica V, Asderakis A, Perrey C et al (1999) In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet 26:1–3PubMedCrossRefGoogle Scholar
  66. Rauramaa R, Vaisanen SB, Luong LA et al (2000) Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol 20:2657–2662PubMedGoogle Scholar
  67. Rea IM, Ross OA, Armstrong M et al (2003) Interleukin-6-gene C/G 174 polymorphism in nonagenarian and octogenarian subjects in the BELFAST study. Reciprocal effects on IL-6,soluble IL-6 receptor and for IL-10 in serum and monocyte supernatants. Mech Ageing Dev 124:555–561PubMedCrossRefGoogle Scholar
  68. Rea IM, Stewart M, Campbell P, Alexander HD, Crockard AD, Morris TC (1996) Changes in lymphocyte subsets, interleukin 2, and soluble interleukin 2 receptor in old and very old age. Gerontology 42:69–78PubMedCrossRefGoogle Scholar
  69. Ross OA, Curran MD, Meenagh A et al (2003) Study of age-association with cytokine gene polymorphisms in an aged Irish population. Mech Ageing Dev 124:199–206PubMedCrossRefGoogle Scholar
  70. Sakao S, Tatsumi K, Igari H et al (2002) Association of tumor necrosis factor-alpha gene promoter polymorphism with low attenuation areas on high-resolution CT in patients with COPD. Chest 122:416–420PubMedCrossRefGoogle Scholar
  71. Salvioli S, Olivieri F, Marchegiani F, Cardelli M, Santoro A, Bellavista E, Mishto M, Invidia L, Capri M, Valensin S, Sevini F, Cevenini E, Celani L, Lescai F, Gonos E, Caruso C, Paolisso G, De Benedictis G, Monti D, Franceschi C (2006) Genes, ageing and longevity in humans: Problems, advantages and perspectives. Free Radic Res 40:1303–1323PubMedCrossRefGoogle Scholar
  72. Scola L, Candore G, Colonna-Romano G, Crivello A, Forte G, Paolisso G, Franceschi C, Lio D, Caruso C (2005). Biogerontology 6:425–429Google Scholar
  73. Shoskes DA, Albakri Q, Thomas K et al (2002) Cytokine polymorphisms in men with chronic prostatitis/chronic pelvic pain syndrome: association with diagnosis and treatment response. J Urol 168:331–335PubMedCrossRefGoogle Scholar
  74. Tagore A, Gonsalkorale WM, Pravica V et al (1999) Interleukin-10 (IL-10) genotypes in inflammatory bowel disease. Tissue Antigens 54:386–390PubMedCrossRefGoogle Scholar
  75. Terry CF, Loukaci V, Green FR (2000) Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 275:18138–18144PubMedCrossRefGoogle Scholar
  76. Turner DM, Williams DM, Sankaran D et al (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24:1–8PubMedGoogle Scholar
  77. Volpato S., Gyralink J, Ferrucci L et al. 2001. Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women’s health and aging study. Circulation. 103:947–953PubMedGoogle Scholar
  78. Wang XY, Hurme M, Jylha M et al (2001). Lack of association between human longevity and polymorphisms of IL-1 cluster, IL-6, IL-10 and TNF-alpha genes in Finnish nonagenarians. Mech Ageing Dev 123:29–38PubMedCrossRefGoogle Scholar
  79. Weber JL, May PE (1989) Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet 44:388–396PubMedGoogle Scholar
  80. Westendorp RG, Langermans JA, Huizinga T et al (1997) Genetic influence on cytokine production in meningococcal disease. Lancet 349:1912–1913PubMedCrossRefGoogle Scholar
  81. Wieczorowska-Tobis K, Niemir Z, Podkywka R, Korybalska K, Mossakowska M, Breborowicz A (2006) Can an increased level of circulating IL-8 be a predictor of human longevity? Med Sci Monit 12(3) :CR118–CR121PubMedGoogle Scholar
  82. Wilson AG, Symons JA, McDowell T et al (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 94:3195–3199PubMedCrossRefGoogle Scholar
  83. Witte JS, Palmer LJ, O’Connor R et al (2002) Relation between tumour necrosis factor polymorphism TNFalpha-308 and risk of asthma. Eur J Hum Genet 10:82–85PubMedCrossRefGoogle Scholar
  84. Wright N, de Lera TL, Garcia-Moruja C, Lillo R, Garcia-Sanchez F, Caruz A, Teixido J (2003) Transforming growth factorbeta1 down-regulates expression of chemokine stromal cell-derived factor-1: Functional consequences in cell migration and adhesion. Blood 102:1978–1984PubMedCrossRefGoogle Scholar
  85. Wright N, de Lera TL, Garcia-Moruja C, Lillo R, Garcia-Sanchez F, Caruz A, Teixido J (2003) Transforming growth factorbeta1Google Scholar
  86. Wu MS, Huang SP, Chang YT et al (2002) Tumor necrosis factor-alpha and interleukin-10 promoter polymorphisms in Epstein-Barr virus-associated gastric carcinoma. J Infect Dis 2002 185:106–109CrossRefGoogle Scholar
  87. Zhang Y, Hayes A, Pritchard A et al (2004) Interleukin-6 promoter polymorphism: risk and pathology of Alzheimer’s disease. Neurosci Lett 362:99–102PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  • Elissaveta Naumova
    • 1
  • Milena Ivanova
    • 1
  1. 1.Central Laboratory of Clinical ImmunologyUniversity Hospital “Alexandrovska”Bulgaria

Personalised recommendations